Financhill
Sell
44

KMB Quote, Financials, Valuation and Earnings

Last price:
$140.21
Seasonality move :
3.53%
Day range:
$138.27 - $140.60
52-week range:
$120.49 - $149.31
Dividend yield:
3.48%
P/E ratio:
18.58x
P/S ratio:
2.36x
P/B ratio:
55.38x
Volume:
2.3M
Avg. volume:
2.2M
1-year change:
16.45%
Market cap:
$46.5B
Revenue:
$20.1B
EPS (TTM):
$7.55

Analysts' Opinion

  • Consensus Rating
    Kimberly-Clark has received a consensus rating of Hold. The company's average rating is a Hold based on 3 Buy ratings, 12 Hold ratings, and 1 Sell rating.
  • Price Target Upside
    According to analysts' consensus price target of $143.84, Kimberly-Clark has an estimated upside of 2.55% from its current price of $140.26.
  • Price Target Downside
    According to analysts, the lowest downside price target is $118.00 representing 100% downside risk from its current price of $140.26.

Fair Value

  • According to the consensus of 16 analysts, Kimberly-Clark has 2.55% upside to fair value with a price target of $143.84 per share.

KMB vs. S&P 500

  • Over the past 5 trading days, Kimberly-Clark has overperformed the S&P 500 by 5.37% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Kimberly-Clark does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Kimberly-Clark revenues have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter Kimberly-Clark reported revenues of $4.9B.

Earnings Growth

  • Kimberly-Clark earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Kimberly-Clark reported earnings per share of $1.34.
Enterprise value:
53.1B
EV / Invested capital:
6.31x
Price / LTM sales:
2.36x
EV / EBIT:
16.60x
EV / Revenue:
2.65x
PEG ratio (5yr expected):
0.41x
EV / Free cash flow:
21.12x
Price / Operating cash flow:
18.81x
Enterprise value / EBITDA:
13.34x
Gross Profit (TTM):
$7.2B
Return On Assets:
14.9%
Net Income Margin (TTM):
12.69%
Return On Equity:
213.79%
Return On Invested Capital:
28.43%
Operating Margin:
11.12%
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-31 2023-12-31 2024-12-31 2023-12-31 2024-12-31
Income Statement
Revenue $20.2B $20.4B $20.1B $5B $4.9B
Gross Profit $6.2B $7B $7.2B $1.7B $1.7B
Operating Income $2.7B $3B $3.3B $670M $548M
EBITDA $3.4B $3.1B $4B $871M $760M
Diluted EPS $5.72 $5.20 $7.55 $1.50 $1.34
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Balance Sheet
Current Assets $5.2B $5.6B $5.7B $5.7B $5.6B
Total Assets $17.5B $17.8B $18B $17.3B $16.5B
Current Liabilities $6.4B $6.7B $7.3B $6.9B $7B
Total Liabilities $16.7B $17.1B $17.3B $16.3B $15.6B
Total Equity $869M $737M $700M $1.1B $975M
Total Debt $8.4B $8.6B $8.4B $8B $7.4B
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-31 2023-12-31 2024-12-31 2023-12-31 2024-12-31
Cash Flow Statement
Cash Flow Operations $2.7B $3.5B $3.2B $1.2B $817M
Cash From Investing -$785M -$418M -$100M -$152M -$194M
Cash From Financing -$1.8B -$2.4B -$3.2B -$754M -$686M
Free Cash Flow $1.9B $2.8B $2.5B $998M $608M
KMB
Sector
Market Cap
$46.5B
$294.3M
Price % of 52-Week High
93.94%
73.38%
Dividend Yield
3.48%
0%
Shareholder Yield
6.32%
3.01%
1-Year Price Total Return
16.45%
-11.91%
Beta (5-Year)
0.412
0.496
Dividend yield:
3.48%
Annualized payout:
$4.88
Payout ratio:
63.97%
Growth streak:
0 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Buy
Level $135.99
200-day SMA
Buy
Level $136.88
Bollinger Bands (100)
Buy
Level 129.06 - 139.52
Chaikin Money Flow
Buy
Level 390M
20-day SMA
Buy
Level $132.35
Relative Strength Index (RSI14)
Buy
Level 71.71
ADX Line
Buy
Level 31.63
Williams %R
Sell
Level -2.7441
50-day SMA
Buy
Level $130.55
MACD (12, 26)
Buy
Level 2.30
25-day Aroon Oscillator
Buy
Level 96
On Balance Volume
Neutral
Level 128.3M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (4.2052)
Sell
CA Score (Annual)
Level (-1.2074)
Buy
Beneish M-Score (Annual)
Level (-2.8031)
Buy
Momentum Score
Level (7)
Sell
Ohlson Score
Level (1.4496)
Buy
Piotroski F Score (Annual)
Level (8)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (9)

Revenue Forecast

Earnings per Share Forecast

Company Profile

With more than half of sales from personal care and another third from consumer tissue products, Kimberly-Clark sits as a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, PullUps, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary offerings for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.

Stock Forecast FAQ

In the current month, KMB has received 3 Buy ratings 12 Hold ratings, and 1 Sell ratings. The KMB average analyst price target in the past 3 months is $143.84.

  • Where Will Kimberly-Clark Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Kimberly-Clark share price will rise to $143.84 per share over the next 12 months.

  • What Do Analysts Say About Kimberly-Clark?

    Analysts are divided on their view about Kimberly-Clark share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Kimberly-Clark is a Sell and believe this share price will drop from its current level to $118.00.

  • What Is Kimberly-Clark's Price Target?

    The price target for Kimberly-Clark over the next 1-year time period is forecast to be $143.84 according to 16 Wall Street analysts, 3 of them rate the stock a Buy, 1 rates the stock a Sell, and 12 analysts rate the stock a Hold.

  • Is KMB A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Kimberly-Clark is a Hold. 12 of 16 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of KMB?

    You can purchase shares of Kimberly-Clark via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Kimberly-Clark shares.

  • What Is The Kimberly-Clark Share Price Today?

    Kimberly-Clark was last trading at $140.21 per share. This represents the most recent stock quote for Kimberly-Clark. Yesterday, Kimberly-Clark closed at $140.26 per share.

  • How To Buy Kimberly-Clark Stock Online?

    In order to purchase Kimberly-Clark stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Cadence Stock a Buy, Sell or Hold?
Is Cadence Stock a Buy, Sell or Hold?

Cadence Design Systems (NASDAQ:CDNS) has seen its stock move sharply…

Is PFE the Best Dividend Play in Its Industry?
Is PFE the Best Dividend Play in Its Industry?

By their inherent nature, established pharma companies face a demand…

What Is SoFi Worth?
What Is SoFi Worth?

Since SoFi’s CEO began snapping up shares of the student…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 40x

Buy
54
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Sell
48
Is MSFT Stock a Buy?

Market Cap: $3T
P/E Ratio: 35x

Alerts

Sell
2
GLOB alert for Feb 22

Globant SA [GLOB] is down 27.81% over the past day.

Sell
42
CELH alert for Feb 22

Celsius Holdings [CELH] is up 27.77% over the past day.

Buy
60
HIMS alert for Feb 22

Hims & Hers Health [HIMS] is down 25.64% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock